SELB Annual CFI
-$15.00 M
+$2.14 M+12.47%
31 December 2022
Summary:
As of February 5, 2025, SELB annual cash flow from investing activities is -$15.00 million, with the most recent change of +$2.14 million (+12.47%) on December 31, 2022. During the last 3 years, it has fallen by -$15.23 million (-6651.09%).SELB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SELB Quarterly CFI
$0.00
+$12.00 K+100.00%
30 September 2023
Summary:
As of February 5, 2025, SELB quarterly cash flow from investing activities is $0.00, with the most recent change of +$12.00 thousand (+100.00%) on September 30, 2023. Over the past year, it has increased by +$29.94 million (+100.00%).SELB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SELB TTM CFI
$33.60 M
+$29.94 M+817.06%
30 September 2023
Summary:
As of February 5, 2025, SELB TTM cash flow from investing activities is $33.60 million, with the most recent change of +$29.94 million (+817.06%) on September 30, 2023. Over the past year, it has increased by +$44.37 million (+412.02%).SELB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SELB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.5% | +100.0% | +412.0% |
| 3 y3 years | -6651.1% | +100.0% | +5853.6% |
| 5 y5 years | -615.1% | -100.0% | +10000.0% |
SELB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -159.4% | -100.0% | at high |
Selecta Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $0.00(-100.0%) | $33.60 M(+817.1%) |
| June 2023 | - | -$12.00 K(-100.0%) | $3.66 M(+2.4%) |
| Mar 2023 | - | $28.12 M(+412.4%) | $3.58 M(-123.8%) |
| Dec 2022 | -$15.00 M(-12.5%) | $5.49 M(-118.3%) | -$15.00 M(+39.3%) |
| Sept 2022 | - | -$29.94 M(>+9900.0%) | -$10.77 M(-162.0%) |
| June 2022 | - | -$99.00 K(-101.0%) | $17.37 M(+16.9%) |
| Mar 2022 | - | $9.54 M(-1.8%) | $14.85 M(-186.6%) |
| Dec 2021 | -$17.14 M(+2213.1%) | $9.72 M(-639.5%) | -$17.14 M(-36.6%) |
| Sept 2021 | - | -$1.80 M(-31.1%) | -$27.03 M(+5.9%) |
| June 2021 | - | -$2.62 M(-88.3%) | -$25.51 M(+10.7%) |
| Mar 2021 | - | -$22.45 M(>+9900.0%) | -$23.05 M(+3010.8%) |
| Dec 2020 | -$741.00 K(-423.6%) | -$166.00 K(-42.0%) | -$741.00 K(+26.9%) |
| Sept 2020 | - | -$286.00 K(+85.7%) | -$584.00 K(-105.2%) |
| June 2020 | - | -$154.00 K(+14.1%) | $11.21 M(-30.8%) |
| Mar 2020 | - | -$135.00 K(+1400.0%) | $16.21 M(+6979.9%) |
| Dec 2019 | $229.00 K | -$9000.00(-100.1%) | $229.00 K(-268.4%) |
| Sept 2019 | - | $11.51 M(+137.6%) | -$136.00 K(-97.6%) |
| June 2019 | - | $4.84 M(-130.1%) | -$5.63 M(-168.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$16.12 M(+4209.9%) | $8.21 M(-67.5%) |
| Dec 2018 | $25.27 M(-1304.6%) | -$374.00 K(-106.2%) | $25.27 M(-20.4%) |
| Sept 2018 | - | $6.02 M(-67.8%) | $31.75 M(+35.9%) |
| June 2018 | - | $18.68 M(+1877.2%) | $23.37 M(+51.9%) |
| Mar 2018 | - | $945.00 K(-84.5%) | $15.38 M(-833.0%) |
| Dec 2017 | -$2.10 M(-90.5%) | $6.11 M(-357.6%) | -$2.10 M(-84.4%) |
| Sept 2017 | - | -$2.37 M(-122.2%) | -$13.41 M(-57.1%) |
| June 2017 | - | $10.70 M(-164.7%) | -$31.25 M(-10.9%) |
| Mar 2017 | - | -$16.53 M(+217.7%) | -$35.08 M(+58.7%) |
| Dec 2016 | -$22.10 M(+372.3%) | -$5.20 M(-74.3%) | -$22.10 M(+11.6%) |
| Sept 2016 | - | -$20.21 M(-394.2%) | -$19.80 M(+2339.0%) |
| June 2016 | - | $6.87 M(-293.2%) | -$812.00 K(-90.0%) |
| Mar 2016 | - | -$3.56 M(+22.2%) | -$8.11 M(+73.3%) |
| Dec 2015 | -$4.68 M(+1961.2%) | -$2.91 M(+139.0%) | -$4.68 M(+164.4%) |
| Sept 2015 | - | -$1.22 M(+183.0%) | -$1.77 M(+220.1%) |
| June 2015 | - | -$430.00 K(+249.6%) | -$553.00 K(+349.6%) |
| Mar 2015 | - | -$123.00 K | -$123.00 K |
| Dec 2014 | -$227.00 K | - | - |
FAQ
- What is Selecta Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Selecta Biosciences?
- What is Selecta Biosciences annual CFI year-on-year change?
- What is Selecta Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Selecta Biosciences?
- What is Selecta Biosciences quarterly CFI year-on-year change?
- What is Selecta Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Selecta Biosciences?
- What is Selecta Biosciences TTM CFI year-on-year change?
What is Selecta Biosciences annual cash flow from investing activities?
The current annual CFI of SELB is -$15.00 M
What is the all time high annual CFI for Selecta Biosciences?
Selecta Biosciences all-time high annual cash flow from investing activities is $25.27 M
What is Selecta Biosciences annual CFI year-on-year change?
Over the past year, SELB annual cash flow from investing activities has changed by +$2.14 M (+12.47%)
What is Selecta Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of SELB is $0.00
What is the all time high quarterly CFI for Selecta Biosciences?
Selecta Biosciences all-time high quarterly cash flow from investing activities is $28.12 M
What is Selecta Biosciences quarterly CFI year-on-year change?
Over the past year, SELB quarterly cash flow from investing activities has changed by +$29.94 M (+100.00%)
What is Selecta Biosciences TTM cash flow from investing activities?
The current TTM CFI of SELB is $33.60 M
What is the all time high TTM CFI for Selecta Biosciences?
Selecta Biosciences all-time high TTM cash flow from investing activities is $33.60 M
What is Selecta Biosciences TTM CFI year-on-year change?
Over the past year, SELB TTM cash flow from investing activities has changed by +$44.37 M (+412.02%)